| Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ... Jama 316 (2), 171-181, 2016 | 1722 | 2016 |
| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1053 | 2019 |
| Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ... The lancet Respiratory medicine 9 (12), 1407-1418, 2021 | 682 | 2021 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 477 | 2021 |
| The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a … J Eron, P Yeni, J Gathe, V Estrada, E DeJesus, S Staszewski, P Lackey, ... The Lancet 368 (9534), 476-482, 2006 | 471 | 2006 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 406 | 2019 |
| HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study A Rodger, T Bruun, V Cambiano, P Vernazza, V Estrada, J Van Lunzen, ... Conference on Retroviruses and Opportunistic Infections, 3-6, 2014 | 349 | 2014 |
| Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals JF Vázquez-Castellanos, S Serrano-Villar, A Latorre, A Artacho, ... Mucosal immunology 8 (4), 760-772, 2015 | 287 | 2015 |
| Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos (t) ide reverse … JR Arribas, PM Girard, R Landman, J Pich, J Mallolas, ... The Lancet Infectious Diseases 15 (7), 785-792, 2015 | 194 | 2015 |
| The CD 4: CD 8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery S Serrano‐Villar, S Moreno, M Fuentes‐Ferrer, C Sánchez‐Marcos, ... HIV medicine 15 (1), 40-49, 2014 | 189 | 2014 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 163 | 2021 |
| Monkeypox outbreak in Madrid (Spain): clinical and virological aspects E Orviz, A Negredo, O Ayerdi, A Vázquez, A Muñoz-Gomez, S Monzón, ... Journal of Infection 85 (4), 412-417, 2022 | 153 | 2022 |
| High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke V Estrada, MJ Téllez, J Moya, R Fernández-Durango, J Egido, ... American journal of hypertension 7 (12), 1085-1089, 1994 | 142 | 1994 |
| High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis F D'Ascenzo, E Cerrato, A Calcagno, W Grossomarra, F Ballocca, ... Atherosclerosis 240 (1), 197-204, 2015 | 127 | 2015 |
| Long-Term Metabolic Consequences of Switching from Protease Inhibitors to Efavirenz in Therapy for Human Immunodeficiency Virus—Infected Patients with Lipoatrophy V Estrada, NGP De Villar, MT Martinez Larrad, AG López, C Fernandez, ... Clinical Infectious Diseases 35 (1), 69-76, 2002 | 127 | 2002 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 125 | 2022 |
| Dyslipidemia related to antiretroviral therapy. V Estrada, J Portilla AIDS reviews 13 (1), 49-56, 2011 | 125 | 2011 |
| Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy V Estrada, MT Martínez-Larrad, JL González-Sánchez, NGP de Villar, ... Metabolism 55 (7), 940-945, 2006 | 124 | 2006 |
| Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19 VM Becerra-Muñoz, IJ Núñez-Gil, CM Eid, M Garcia Aguado, R Romero, ... Age and ageing 50 (2), 326-334, 2021 | 122 | 2021 |
| Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: The PARTNER2 Study extended results in gay men A Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, GM Corbelli, ... Journal of the International AIDS Society 21 (Supplement 6), 163-163, 2018 | 122 | 2018 |
